Free Trial
NASDAQ:PRE

Prenetics Global Q3 2024 Earnings Results & Report

Prenetics Global logo
$16.57 -0.15 (-0.90%)
As of 11:31 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Prenetics Global reported Q3 2024 earnings on November 27, 2024. The company reported EPS of -$0.84.

Earnings Announcement Details

Quarter
Q3 2024
Time
Before Market Opens

Prenetics Global EPS Results

Actual EPS
-$0.84
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A
EPS Beat Rate
5 of last 6 quarters

Prenetics Global Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Upcoming Earnings

Prenetics Global's Q3 2026 earnings is estimated for Wednesday, November 18, 2026, based on past reporting schedules, with a conference call scheduled at 8:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Conference Call Resources

Prenetics Global Q3 2024 Earnings FAQ

Prenetics Global (NASDAQ:PRE) reported earnings of -$0.84 per share for Q3 2024. The report was announced on Wednesday, November 27, 2024.

Prenetics Global's next earnings date is estimated for Wednesday, November 18, 2026. MarketBeat tracks confirmed and estimated earnings dates for Prenetics Global on the company's earnings history page.

Prenetics Global Earnings Headlines

PRE Announces Strategic Partnership
My next big call (under $1)
17,556% on KDA. 3,900% on PRE. 2,650% on OCEAN. Every single one of these was recommended to our community before the big move happened. Now, I'm making my next big call. It's a coin under $1.00 that most investors have never heard of. But the world's largest bank is already building on it. It has a deflationary burn mechanism tied directly to institutional usage. With Bitcoin well off its highs and fear still hanging over the market, this is the exact environment where my biggest winners have been found.tc pixel
Prenetics Global Names Brian Rosin to Succeed Stephen Lo as CFO
See More Prenetics Global Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Prenetics Global? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Prenetics Global and other key companies, straight to your email.

About Prenetics Global

Prenetics Global (NASDAQ:PRE) is a health sciences company focused on consumer wellness and health-related products. Its portfolio includes IM8, a consumer wellness brand offering nutritional supplements, and CircleDNA, a genetic testing service that provides reports on health, wellness and ancestry.

The company has also operated clinical genomic testing services and provided COVID-19 testing during the pandemic. Its business has since shifted toward consumer health and wellness.

Prenetics was founded in 2014 and is led by co-founder and Chief Executive Officer Danny Yeung. The company has roots in Hong Kong and has served customers in multiple markets through its testing and consumer health businesses.

View Prenetics Global Profile